Merck
  • Home
  • Search Results
  • Losartan and Sodium Nitroprusside Effectively Protect against Renal Impairments after Ischemia and Reperfusion in Rats.

Losartan and Sodium Nitroprusside Effectively Protect against Renal Impairments after Ischemia and Reperfusion in Rats.

Biological & pharmaceutical bulletin (2015-05-08)
Umarat Srisawat, Surachai Kongrat, Chatchai Muanprasat, Varanuj Chatsudthipong
ABSTRACT

Ischemia and subsequent reperfusion are known to impair renal function. We examined several agents that might prevent renal impairment or enhance the recovery of renal function after ischemia/reperfusion injury in rats. Different degrees of preventive effects were observed in rats treated with captopril, BQ-123 (endothelin type A receptor antagonist), sodium nitroprusside (SNP, a nitric oxide donor), and losartan (angiotensin II type 1 receptor antagonist). Only minimal changes in renal morphology were observed after treatment with losartan, SNP, captopril, and BQ-123 compared with control animals. On the other hand, lesions were prominent in the N(G)-nitro-L-arginine-methyl ester (L-NAME)- and L-arginine-treated rats. The Na(+)-K(+) ATPase activity of ischemic kidneys was, however, preserved in all treatment groups, except in those treated with L-arginine and L-NAME, which showed a marked reduction in Na(+)-K(+) ATPase activity. Our post-treatment data suggest that losartan and SNP have the greatest potential for therapeutic use to mitigate post-ischemic renal damage and functional impairment.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anthrone, ACS reagent, 97%
Sigma-Aldrich
Potassium hydride, in paraffin
Sigma-Aldrich
Potassium, cubes (in mineral oil), 99.5% trace metals basis
Sigma-Aldrich
L-Arginine, from non-animal source, meets EP, USP testing specifications, suitable for cell culture, 98.5-101.0%
Sigma-Aldrich
L-Arginine, reagent grade, ≥98%
Sigma-Aldrich
BQ-123, ≥99%, sodium salt, lyophilized powder
Sigma-Aldrich
Captopril, meets USP testing specifications
Sigma-Aldrich
Captopril, ≥98% (HPLC), powder
Sigma-Aldrich
L-Arginine, 99%, FCC, FG
Sigma-Aldrich
Potassium, ingot, 99.95% trace metals basis
Sigma-Aldrich
Nitric oxide, 98.5%
Sigma-Aldrich
Potassium, chunks (in mineral oil), 98% trace metals basis
Sigma-Aldrich
Potassium hydride, 30 wt % dispersion in mineral oil
SAFC
L-Arginine